Nanostart invests in Singapore medical technology company BioMers
Nanostart majority-owned MagForce Nanotechnologies AG names Dr. Peter Heinrich as new CEO
Nanostart further increases ownership of ItN Nanovation
Nanostart-owned MagForce Nanotechnologies AG: Application submitted for EU regulatory approval of Nano-Cancer® therapy
Nanostart to feature successful completion of MagForce clinical trials at investor presentation in New York City
Nanostart majority-owned MagForce announces successful completion of final clinical trials for Nano-Cancer® therapy
Nanostart increases investment in promising portfolio company Curiox
An interview with Lutz Bungeroth, chairman of Nanostart holding ItN Nanovation AG
Nanocoating by Nanostart holding ItN Nanovation is flying to the Mercury
Nanostart subsidiary MagForce: Patient recruitment for phase II clinical trials for Nano-Cancer® therapy successfully completed
Print page
Deutsch
English
Русский
中文
日本語
Français
Español